Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Cancer of Ovary

cetylpyridinium chloride anhydrous has been researched along with Cancer of Ovary in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, M; Liu, B; Sa, M; Tang, A; Xiang, Z; Yang, J1
Joo, J; Kim, SI; Lee, DO; Lee, Y; Lim, MC; Park, K; Park, SY1
Beller, U; Eitan, R; Levavi, H; Michaelson-Cohen, R1
Alexandre, J; Arenzana-Seisdedos, F; Balabanian, K; Bouchet-Delbos, L; Broët, P; Camilleri-Broët, S; Emilie, D; Gaudin, F; Gladieff, L; Machelon, V; Nasreddine, S; Prévot, S; Pujade-Lauraine, E1
Robertson, DM1
Chiang, CL; Coukos, G; Czerniecki, BJ; Garrabrant, T; Hagemann, AR; Kandalaft, LE; Leskowitz, R; Mick, R; Powell, DJ1
Ahmad, S; Ahmed, A; Edwards, CR; Edwards, JR; Finkler, NJ; Holloway, RW; Ingersoll, SB; Merchant, MH; Oyer, JL; Stoltzfus, GP1
Balkwill, FR; Burke, F; Grimshaw, MJ; Hagemann, T; Stamp, G; Szlosarek, PW; Wilbanks, GD; Wilson, JL1
Maclean, U1

Reviews

2 review(s) available for cetylpyridinium chloride anhydrous and Cancer of Ovary

ArticleYear
The counseling and management of young healthy BRCA mutation carriers.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:7

    Topics: Breast Neoplasms; Counseling; Disease Management; Female; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Health; Heterozygote; Humans; Mutation; Ovarian Neoplasms

2009
Inhibins and activins in blood: predictors of female reproductive health?
    Molecular and cellular endocrinology, 2012, Aug-15, Volume: 359, Issue:1-2

    Topics: Activins; Animals; Biomarkers; Female; Health; Humans; Infertility, Female; Inhibins; Menopause; Ovarian Follicle; Ovarian Neoplasms; Pregnancy; Pregnancy Complications; Reproduction

2012

Other Studies

7 other study(ies) available for cetylpyridinium chloride anhydrous and Cancer of Ovary

ArticleYear
The reference intervals for HE4, CA125 and ROMA in healthy female with electrochemiluminescence immunoassay.
    Clinical biochemistry, 2013, Volume: 46, Issue:16-17

    Topics: Aging; Algorithms; CA-125 Antigen; Female; Health; Humans; Immunoassay; Luminescent Measurements; Ovarian Neoplasms; Postmenopause; Premenopause; Proteins; Reference Values; Risk Factors; WAP Four-Disulfide Core Domain Protein 2

2013
Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women.
    Journal of gynecologic oncology, 2015, Volume: 26, Issue:2

    Topics: Adult; Case-Control Studies; Cross-Sectional Studies; Female; Health; Humans; Middle Aged; Ovarian Neoplasms; Quality of Life; Sexual Behavior; Sexuality; Socioeconomic Factors; Surveys and Questionnaires; Survivors

2015
CXCL12 expression by healthy and malignant ovarian epithelial cells.
    BMC cancer, 2011, Mar-16, Volume: 11

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Chemokine CXCL12; Clinical Trials, Phase III as Topic; Cohort Studies; Epithelial Cells; Female; Health; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Predictive Value of Tests; Randomized Controlled Trials as Topic

2011
Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.
    PloS one, 2011, Volume: 6, Issue:12

    Topics: Cell Differentiation; Cell Line, Tumor; Cross-Priming; Cytokines; Dendritic Cells; Female; Health; Humans; Interferon-gamma; Lipopolysaccharides; Myeloid Cells; Ovarian Neoplasms; Phagocytosis; Phenotype; T-Lymphocytes; Tissue Donors; Tissue Extracts

2011
Comparison of the cytotoxic response against ovarian cancer by immune effector cells isolated and expanded from normal donors and ovarian cancer patients.
    Cytotherapy, 2012, Volume: 14, Issue:6

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Separation; Cytotoxicity, Immunologic; Female; Flow Cytometry; Health; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Mice; Ovarian Neoplasms; Recombinant Proteins; T-Lymphocytes; Tissue Donors

2012
Aberrant regulation of argininosuccinate synthetase by TNF-alpha in human epithelial ovarian cancer.
    International journal of cancer, 2007, Jul-01, Volume: 121, Issue:1

    Topics: Argininosuccinate Synthase; Epithelial Cells; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Health; Humans; Ovarian Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2007
Women and health in Europe: the scope and limits of epidemiology.
    International journal of health services : planning, administration, evaluation, 1985, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Breast Neoplasms; Cardiovascular Diseases; Colonic Neoplasms; Contraceptives, Oral; Epidemiology; Europe; Female; Health; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Socioeconomic Factors; Stomach Neoplasms; Uterine Cervical Neoplasms; Women; Women, Working

1985